The role of digoxin in atrial fibrillation.

5 April 2022 (08:42 - 08:54)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Paulus Kirchhof

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

4 More presentations in this session

Presentation thumbnail

AV nodal blocking therapy in AF: when, how and for whom?

Professor S. Boveda (Toulouse, FR)

Presentation thumbnail

The role of a calcium channel blocker in atrial fibrillation.

Doctor R. Tieleman (Groningen, NL)

Presentation thumbnail

Ablate and pace: the preferred therapy now?

Professor P. Vardas (Heraklion, GR)

Presentation thumbnail

Is there still room for drugs to control AV nodal conduction in AF? - discussion.

Access the full session

Session thumbnail

Is there still room for drugs to control atrioventricular nodal conduction in atrial fibrillation (AF)?

The Event

Event poster

EHRA 2022

5 April 2022 08:42 CET

You may be interested in

Congress Session

Treatment strategies for atrial fibrillation in heart failure

Congress Session

EHRA Myths - Device-detected atrial fibrillation

Congress Session

Stroke prevention in clinical and subclinical atrial fibrillation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources